This Health Drink Company Has Strong Buy Signals

CelsiusCelsius Holdings Inc. (NASDAQ: CELH) is a nutritional beverage and supplement company. Its most popular product is the CELSIUS® Fitness Drink, a clinically proven calorie-burning beverage that is available in natural fruit flavors. The global beverage market is changing, with consumers looking for healthier alternatives to sodas and energy drinks. CELSIUS® fits into the market perfectly. Although the products do contain caffeine, they also have more natural beneficial compounds than the average energy drink brand.

7 of the Biggest Mistakes People Make When Choosing a Financial Advisor Learn More

Celsius earnings are driving confidence and growth in this stock. The company released third-quarter earnings this month, reporting revenue of $20.4 million, a year over year increase of 23%. This was the best quarter on record so far. Income was also strong with earnings per share of $0.03. Overall, year to date revenue growth was tracking at 52% at the end of the third quarter. The company attributed this to “demand for our portfolio and our ability to execute and drive profitable growth.”

Celsius stock is a bargain today, and there’s strong upside potential. Analysts recorded on FactSet recommend a BUY rating, with an average target price of $10. Any investor looking for a small-cap stock with top-end potential should consider this in the fourth quarter.

Key Data:

  • 1 Year Price Growth: 32%
  • YTD Price Growth: 82%
  • 3 Month Price Growth: 45%

All information is based on current and historical market data, as well as publicly available financial data. As with any financial decision, your own research is important. Stock market outcomes can never be 100% accurately predicted. Familiarity with historical data, individual industries, and individual stocks is key to developing a robust portfolio. Note that stock prices can fluctuate rapidly during trading sessions.

 

The reports, research and newsletter are based on current and historical market data, as well as publicly available financial data.They are intended to be a starting point for investors. They do not provide every material fact about a company or industry, nor are they recommendations to buy or sell. The writers and the company make no warranties or representations as to the accuracy of these reports.   You should NOT rely solely upon the information or opinions read in the content. Rather, you should use the content as a starting point for doing independent research on the independent analysis and trading methods in the content. The content is impersonal and does not provide individualized advice or recommendations for any specific reader or individual portfolio. By accessing this website you have agreed to our disclaimers and privacy policy.

 

 

The reports, research and newsletter are based on current and historical market data, as well as publicly available financial data.They are intended to be a starting point for investors. They do not provide every material fact about a company or industry, nor are they recommendations to buy or sell. The writers and the company make no warranties or representations as to the accuracy of these reports.   You should NOT rely solely upon the information or opinions read in the content. Rather, you should use the content as a starting point for doing independent research on the independent analysis and trading methods in the content. The content is impersonal and does not provide individualized advice or recommendations for any specific reader or individual portfolio. By accessing this website you have agreed to our disclaimers and privacy policy.

 

You May Also Like